Cargando…

Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies

PURPOSE: (S)-4-(3-[(18)F]Fluoropropyl)-L-glutamic acid (18F-FSPG) is a novel radiopharmaceutical for Positron Emission Tomography (PET) imaging. It is a glutamate analogue that can be used to measure x(C)(-) transporter activity. This study was performed to assess the feasibility of 18F-FSPG for ima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mittra, Erik S., Koglin, Norman, Mosci, Camila, Kumar, Meena, Hoehne, Aileen, Keu, Khun Visith, Iagaru, Andrei H., Mueller, Andre, Berndt, Mathias, Bullich, Santiago, Friebe, Matthias, Schmitt-Willich, Heribert, Gekeler, Volker, Fels, Lüder M., Bacher-Stier, Claudia, Moon, Dae Hyuk, Chin, Frederick T., Stephens, Andrew W., Dinkelborg, Ludger M., Gambhir, Sanjiv S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758607/ https://www.ncbi.nlm.nih.gov/pubmed/26890637 http://dx.doi.org/10.1371/journal.pone.0148628

Ejemplares similares

Initial evaluation of (4S)-4-(3-[(18)F]fluoropropyl)-l-glutamate (FSPG) PET/CT imaging in patients with head and neck cancer, colorectal cancer, or non-Hodgkin lymphoma
por: Park, Sonya Y., et al.
Publicado: (2020)

Synthesis and analysis of 4-(3-fluoropropyl)-glutamic acid stereoisomers to determine the stereochemical purity of (4S)-4-(3-[(18)F]fluoropropyl)-L-glutamic acid ([(18)F]FSPG) for clinical use
por: Shih, Kai-Ting, et al.
Publicado: (2020)

Robust and Facile Automated Radiosynthesis of [(18)F]FSPG on the GE FASTlab
por: Edwards, Richard, et al.
Publicado: (2021)

(18)F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules
por: Paez, Rafael, et al.
Publicado: (2022)

Radiosynthesis and Analysis of (S)-4-(3-[(18)F]Fluoropropyl)-L-Glutamic Acid
por: Brown, Gavin, et al.
Publicado: (2022)

Simplified and Highly-reliable automated production of [(18)F]FSPG for clinical studies
por: Lin, Mai, et al.
Publicado: (2023)

Simplified and highly-reliable automated production of [(18)F]FSPG for clinical studies
por: Lin, Mai, et al.
Publicado: (2023)

[(18)F]FSPG-PET reveals increased cystine/glutamate antiporter (xc-) activity in a mouse model of multiple sclerosis
por: Hoehne, Aileen, et al.
Publicado: (2018)

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent
por: Wu, Zehui, et al.
Publicado: (2014)

Synthesis and Biological Evaluation of O-[3-(18)F-fluoropropyl]-α-methyl Tyrosine in Mesothelioma-Bearing Rodents
por: Shih, I-Hong, et al.
Publicado: (2013)

An Observational Study of Circulating Tumor Cells and (18)F-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer
por: Nair, Viswam S., et al.
Publicado: (2013)

PET Imaging with [(18)F]FSPG Evidences the Role of System xc(-) on Brain Inflammation Following Cerebral Ischemia in Rats
por: Domercq, Maria, et al.
Publicado: (2016)

Commentary to (18)F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi: Imaging Activated Platelets in Clots—Are We Getting There?
por: Stephens, Andrew W., et al.
Publicado: (2018)

(18)F-Florbetaben PET beta-amyloid binding expressed in Centiloids
por: Rowe, Christopher C., et al.
Publicado: (2017)

PET Imaging a MPTP-Induced Mouse Model of Parkinson’s Disease Using the Fluoropropyl-Dihydrotetrabenazine Analog [(18)F]-DTBZ (AV-133)
por: Toomey, James S., et al.
Publicado: (2012)

A Multi-Atlas-Based [18F]9-Fluoropropyl-(+)-Dihydrotetrabenazine Positron Emission Tomography Image Segmentation Method for Parkinson’s Disease Quantification
por: Pan, Yiwei, et al.
Publicado: (2022)

Feasibility of [(18)F]FSPG PET for Early Response Assessment to Combined Blockade of EGFR and Glutamine Metabolism in Wild-Type KRAS Colorectal Cancer
por: Bae, Seong-Woo, et al.
Publicado: (2023)

Imaging patients with breast and prostate cancers using combined 18F NaF/18F FDG and TOF simultaneous PET/ MRI
por: Iagaru, Andrei, et al.
Publicado: (2015)

Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson’s disease using in vivo (18)F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging
por: Weng, Chi-Chang, et al.
Publicado: (2017)

Optimized dual-time-window protocols for quantitative [(18)F]flutemetamol and [(18)F]florbetaben PET studies
por: Heeman, Fiona, et al.
Publicado: (2019)

Optimized classification of (18)F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment
por: Bullich, Santiago, et al.
Publicado: (2017)

Simulating the effect of cerebral blood flow changes on regional quantification of [(18)F]flutemetamol and [(18)F]florbetaben studies
por: Heeman, Fiona, et al.
Publicado: (2020)

Early detection of amyloid load using (18)F-florbetaben PET
por: Bullich, Santiago, et al.
Publicado: (2021)

(18)F-NaF and (18)F-FDG as molecular probes in the evaluation of atherosclerosis
por: McKenney-Drake, Mikaela L., et al.
Publicado: (2018)

[(18)F]Tosyl fluoride as a versatile [(18)F]fluoride source for the preparation of (18)F-labeled radiopharmaceuticals
por: Zhou, Dong, et al.
Publicado: (2023)

(18)F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition
por: Baratto, Lucia, et al.
Publicado: (2018)

Evaluation of tau deposition using (18)F-PI-2620 PET in MCI and early AD subjects—a MissionAD tau sub-study
por: Bullich, Santiago, et al.
Publicado: (2022)

Initial investigation of (18)F-NaF PET/CT for identification of vertebral sites amenable to surgical revision after spinal fusion surgery
por: Quon, Andrew, et al.
Publicado: (2012)

Fully automated (18)F-fluorination of N-succinimidyl-4-[(18)F]fluorobenzoate ([(18)F]SFB) for indirect labelling of nanobodies
por: Nagachinta, Surasa, et al.
Publicado: (2022)

Investigation of 6-[(18)F]-Fluoromaltose as a Novel PET Tracer for Imaging Bacterial Infection
por: Gowrishankar, Gayatri, et al.
Publicado: (2014)

(18)F-Sodium Fluoride ((18)F-NaF) for Imaging Microcalcification Activity in the Cardiovascular System
por: Tzolos, Evangelos, et al.
Publicado: (2020)

Automated radiosynthesis of two (18)F-labeled tracers containing 3-fluoro-2-hydroxypropyl moiety, [(18)F]FMISO and [(18)F]PM-PBB3, via [(18)F]epifluorohydrin
por: Ohkubo, Takayuki, et al.
Publicado: (2021)

(18)F-Fluciclovine ((18)F-FACBC) PET imaging of recurrent brain tumors
por: Michaud, Laure, et al.
Publicado: (2019)

Comparison of (18)F-FDG, (18)F-Fluoroacetate, and (18)F-FEPPA for Imaging Liver Fibrosis in a Bile Duct-Ligated Rat Model
por: Wu, Chun-Yi, et al.
Publicado: (2021)

On-demand radiosynthesis of N-succinimidyl-4-[(18)F]fluorobenzoate ([(18)F]SFB) on an electrowetting-on-dielectric microfluidic chip for (18)F-labeling of protein
por: Kim, Hee-Kwon, et al.
Publicado: (2019)

18F-NaF Positive Bone Metastases of Non 18F-FDG Avid Mucinous Gastric Cancer
por: Soydal, Çiğdem, et al.
Publicado: (2015)

Synthesis of [(18)F]Arenes via the Copper-Mediated [(18)F]Fluorination of Boronic Acids
por: Mossine, Andrew V., et al.
Publicado: (2015)

(18)F-fluorodeoxyglucose and (18)F-flumazenil positron emission tomography in patients with refractory epilepsy
por: Hodolic, Marina, et al.
Publicado: (2016)

(18)F-Fluorodeoxyglucose Uptake and Tumor Hypoxia: Revisit (18)F-Fluorodeoxyglucose in Oncology Application
por: Li, Xiao-Feng, et al.
Publicado: (2014)

Comparison of New Tau PET-Tracer Candidates With [(18)F]T808 and [(18)F]T807
por: Declercq, Lieven, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_okn0qgomu6bnlim6p213vl3s6t